Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04372017 · ClinicalTrials.gov registry record · Phase 3
Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection
A Phase 3 study, sponsored by Sanford Health.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT04372017 is a Phase 3 study that was terminated before completion, run by Sanford Health. The registered enrollment target is 1 participants.
The verdict
NCT04372017, a Phase 3 study, was terminated before completion, sponsored by Sanford Health.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a prospective, double-blind, randomized, placebo-controlled study in two distinct cohorts to evaluate the efficacy and safety of hydroxychloroquine in the prevention of COVID-19 infection.
Interventions
- DIETARY_SUPPLEMENT Vitamin D
- DRUG Hydroxychloroquine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-05-14 |
| Est. Completion | 2021-06-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04372017
The ClinicalTrials.gov registry entry for NCT04372017 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin D is the first listed.
NCT04372017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04372017 about?
NCT04372017 is a clinical study titled "Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection". This is a prospective, double-blind, randomized, placebo-controlled study in two distinct cohorts to evaluate the efficacy and safety of hydroxychloroquine in the prevention of COVID-19 infection.
What is the current status of trial NCT04372017?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2020-05-14. Estimated completion is 2021-06-04.
What interventions are being tested in trial NCT04372017?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT), Hydroxychloroquine (DRUG).
Who is sponsoring clinical trial NCT04372017?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.